Cargando…
Predicting leukemic transformation in myelodysplastic syndrome using a transcriptomic signature
Background: For prediction on leukemic transformation of MDS patients, emerging model based on transcriptomic datasets, exhibited superior predictive power to traditional prognostic systems. While these models were lack of external validation by independent cohorts, and the cell origin (CD34(+) sort...
Autores principales: | Guo, Chao, Gao, Ya-Yue, Li, Zhen-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634373/ https://www.ncbi.nlm.nih.gov/pubmed/37953918 http://dx.doi.org/10.3389/fgene.2023.1235315 |
Ejemplares similares
-
FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
por: Schieber, Michael, et al.
Publicado: (2020) -
Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosis
por: Hong, Minghua, et al.
Publicado: (2021) -
SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome
por: Ma, Yan, et al.
Publicado: (2015) -
Fatal right‐sided heart failure due to leukostasis in a patient with leukemic transformation of myelodysplastic syndrome
por: Pryds, Kasper, et al.
Publicado: (2018) -
SET Domain Containing 2 Deficiency in Myelodysplastic Syndrome
por: Li, Jiaming, et al.
Publicado: (2020)